Back to Stocks

ARAY

ACCURAY INC
7 filings tracked
healthcaremedical devicesSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Accuray is currently navigating a decisive operational pivot aimed at establishing a sustainable path to profitability.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The financial reality for Accuray is increasingly precarious, characterized by significant cash burn and a balance sheet that resembles a ticking time bomb.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every ARAY filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Accuray's latest filing reveals a company at a crossroads, attempting to outrun a liquidity crisis through a comprehensive organizational overhaul. The tension between the bull case of a lean, services-oriented future and the bear case of imminent insolvency is palpable. While the Transformation Plan aims to reduce the burn rate, the immediate pressure from high-interest debt and a shrinking cash pile limits the margin for error. The overall impact of the filing is a heightened risk profile for investors. The success of the turnaround now hinges on the company's ability to convert its aging backlog into cash and successfully navigate the complex geopolitical landscape in China. Until Accuray can demonstrate positive operating cash flow and stabilize its margins, the market is likely to remain focused on the looming debt maturities and the fragility of its balance sheet.

Selected Quarter

Core Takeaway

The company is aggressively cutting costs via a Transformation Plan, but high debt interest and falling margins are depleting cash reserves faster than the pivot can take hold.

Investor Lens

The trade-off is between the ability to execute a strategic cost-cutting turnaround and the immediate risk of a liquidity-driven collapse.

Watch Next

The December 31, 2026 deadline for fixed charge coverage and leverage ratio covenant compliance.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.23Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%
bearishMay 6

Gross margins declined to 25.4% due to higher logistics and component costs.

margin compression
70%
neutralMay 6

Amended Financing Agreement delayed covenant testing to December 2026.

debt restructure
50%
bullishMay 6

Implementation of FY26 Transformation Plan to right-size global workforce and costs.

management change
60%
bearishMay 6

Net loss of $47.3 million over nine months ended March 31, 2026.

earnings miss
80%

Filing History

10-QMay 6, 2026
Expand Sequence

Accuray's latest filing reveals a company at a crossroads, attempting to outrun a liquidity crisis through a comprehensive organizational overhaul. The tension between the bull case of a lean, services-oriented future and the bear case of imminent insolvency is palpable. While the Transformation Plan aims to reduce the burn rate, the immediate pressure from high-interest debt and a shrinking cash pile limits the margin for error. The overall impact of the filing is a heightened risk profile for investors. The success of the turnaround now hinges on the company's ability to convert its aging backlog into cash and successfully navigate the complex geopolitical landscape in China. Until Accuray can demonstrate positive operating cash flow and stabilize its margins, the market is likely to remain focused on the looming debt maturities and the fragility of its balance sheet.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.